{"doi":"10.1165/rcmb.2021-0357oc","title":"eNAMPT Is a Novel Damage-associated Molecular Pattern Protein That Contributes to the Severity of Radiation-Induced Lung Fibrosis","abstract":"Abstract The paucity of therapeutic strategies to reduce the severity of radiation-induced lung fibrosis (RILF), a life-threatening complication of intended or accidental ionizing radiation exposure, is a serious unmet need. We evaluated the contribution of eNAMPT (extracellular nicotinamide phosphoribosyltransferase), a damage-associated molecular pattern (DAMP) protein and TLR4 (Toll-like receptor 4) ligand, to the severity of whole-thorax lung irradiation (WTLI)-induced RILF. Wild-type (WT) and Nampt +/− heterozygous C57BL6 mice and nonhuman primates (NHPs, Macaca mulatta) were exposed to a single WTLI dose (9.8 or 10.7 Gy for NHPs, 20 Gy for mice). WT mice received IgG1 (control) or an eNAMPT-neutralizing polyclonal or monoclonal antibody (mAb) intraperitoneally 4 hours after WTLI and weekly thereafter. At 8–12 weeks after WTLI, NAMPT expression was assessed by immunohistochemistry, biochemistry, and plasma biomarker studies. RILF severity was determined by BAL protein/cells, hematoxylin and eosin, and trichrome blue staining and soluble collagen assays. RNA sequencing and bioinformatic analyses identified differentially expressed lung tissue genes/pathways. NAMPT lung tissue expression was increased in both WTLI-exposed WT mice and NHPs. Nampt +/− mice and eNAMPT polyclonal antibody/mAb-treated mice exhibited significantly attenuated WTLI-mediated lung fibrosis with reduced: 1) NAMPT and trichrome blue staining; 2) dysregulated lung tissue expression of smooth muscle actin, p-SMAD2/p-SMAD1/5/9, TGF-β, TSP1 (thrombospondin-1), NOX4, IL-1β, and NRF2; 3) plasma eNAMPT and IL-1β concentrations; and 4) soluble collagen. Multiple WTLI-induced dysregulated differentially expressed lung tissue genes/pathways with known tissue fibrosis involvement were each rectified in mice receiving eNAMPT mAbs.The eNAMPT/TLR4 inflammatory network is essentially involved in radiation pathobiology, with eNAMPT neutralization an effective therapeutic strategy to reduce RILF severity.","journal":"American Journal of Respiratory Cell and Molecular Biology","year":2022,"id":246596,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":37,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9653,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2022-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":688433,"name":"Nancy G. Casanova","orcid":"0000-0002-6363-2414","position":1,"is_corresponding":false},{"id":688890,"name":"Carrie L. Kempf","orcid":null,"position":2,"is_corresponding":false},{"id":688892,"name":"Tadeo Bermudez","orcid":null,"position":3,"is_corresponding":false},{"id":688434,"name":"Daniel G. Valera","orcid":"0000-0003-4450-4510","position":4,"is_corresponding":false},{"id":392783,"name":"Jin H. Song","orcid":"0000-0002-0123-2909","position":5,"is_corresponding":false},{"id":688435,"name":"Xiaoguang Sun","orcid":"0000-0003-4226-8294","position":6,"is_corresponding":false},{"id":624016,"name":"Hua Cai","orcid":"0000-0002-6697-652X","position":7,"is_corresponding":false},{"id":883912,"name":"Liliana Moreno-Vinasco","orcid":null,"position":8,"is_corresponding":false},{"id":688895,"name":"Taylor Gregory","orcid":null,"position":9,"is_corresponding":false},{"id":523885,"name":"Radu C. Oita","orcid":"0009-0001-0478-5103","position":10,"is_corresponding":false},{"id":688896,"name":"Vivian Reyes Hernon","orcid":null,"position":11,"is_corresponding":false},{"id":883248,"name":"Sara M. Camp","orcid":"0000-0001-5521-9841","position":12,"is_corresponding":false},{"id":883913,"name":"Claude Rogers","orcid":null,"position":13,"is_corresponding":false},{"id":752697,"name":"Espoir M. Kyubwa","orcid":null,"position":14,"is_corresponding":false},{"id":751964,"name":"Naresh Menon","orcid":"0000-0003-1359-6280","position":15,"is_corresponding":false},{"id":883914,"name":"James Axtelle","orcid":null,"position":16,"is_corresponding":false},{"id":237299,"name":"Jay Rappaport","orcid":"0000-0001-7916-3571","position":17,"is_corresponding":false},{"id":231631,"name":"Christian Bime","orcid":"0000-0003-4787-2685","position":18,"is_corresponding":false},{"id":688438,"name":"Saad Sammani","orcid":"0000-0002-7933-6388","position":19,"is_corresponding":false},{"id":531923,"name":"Anne E. Cress","orcid":"0000-0001-6194-0061","position":20,"is_corresponding":false},{"id":300875,"name":"Joe G. N. Garcia","orcid":"0000-0002-6934-0420","position":21,"is_corresponding":false},{"id":882647,"name":"Alexander N. Garcia","orcid":null,"position":0,"is_corresponding":true}],"reference_count":82,"raw_metadata":null,"created_at":"2026-07-19T00:23:48.622830Z","pmid":"35167418","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}